Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by Mercuryfilling1on Dec 02, 2022 6:28pm
242 Views
Post# 35147888

RE:How many patients do they plan to treat in this phase of res

RE:How many patients do they plan to treat in this phase of res
edrose wrote: Research and how will it take to get data to see if technology works in helping patients with diabetes 
do they have enough money to complete study


I like your style, Edrose. Sort of a cross between Jack Kerouac's stream of conciousness and Fred Munster :)

Isn't it interesting that the critical mineral play that you and I (and others here) are part of, closed for the week at exactly the same price!  It's written in the stars Ed. Don't worry about patient numbers and money supply. This is a penny stock (until it isn't)...play the momentum, just like last January. You'll make money.  If you were paying attention last Jan/Feb, you would have made A LOT.
<< Previous
Bullboard Posts
Next >>